Methods and compositions for the detection of soluble beta-amyloid peptide

Details for Australian Patent Application No. 2004203875 (hide)

International Classifications

Event Publications

2 September 2004 Complete Application Filed

9 September 2004 Application Open to Public Inspection

Published as AU-A-2004203875

2 March 2006 Amendment Made

The nature of the amendment is: Amend the name of the applicants from Eli Lilly and Company Brigham and Women's Hospital, Elan Pharmaceuticals, Inc. to Eli Lilly and Company, The Brigham and Women's Hospital, Inc.and Elan Pharmaceuticals, Inc.

28 February 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.